BMJ Best Practice

参考文献

关键文献

World Health Organization. Primary health care level management of trachoma. http://www.who.int (last accessed 30 March 2016).

World Health Organization. Trachoma control: a guide for programme managers. 2006. http://www.who.int (last accessed 30 March 2016).

Evans JR, Solomon AW. Antibiotics for trachoma. Cochrane Database Syst Rev. 2011;(3):CD001860.

Dawson CR, Schachter J, Sallam S, et al. A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. Clin Infect Dis. 1997;24:363-368.

Harding-Esch EM, Sillah A, Edwards T, et al; Partnership for Rapid Elimination of Trachoma (PRET) study group. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia. PLoS Negl Trop Dis. 2013;7:e2115.

Lietman T, Porco T, Dawson C, et al. Global elimination of trachoma: how frequently should we administer mass chemotherapy. Nature Med. 1999;5:572-576.

Ejere HO, Alhassan MB, Rabiu M. Face washing promotion for preventing active trachoma. Cochrane Database Syst Rev. 2015;(2):CD003659.

Ngondi J, Onsarigo A, Matthews F, et al. Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: a cross-sectional study. Lancet. 2006;368:589-595.

Bowman RJ, Faal H, Myatt M, et al. Longitudinal study of trachomatous trichiasis in the Gambia. Br J Ophthalmol. 2002;86:339-343.

Reacher M, Foster A, Huber J. Trichiasis surgery for trachoma: the bilamellar tarsal rotation procedure. Geneva, Switzerland: WHO; 1998;WHO/PBL/93.29.

West ES, Munoz B, Imeru A, et al. The association between epilation and corneal opacity in eye with trachomatous trichiasis. Br J Ophthalmol. 2006;90:171-174.

参考文章

1.  Polack S, Brooker S, Kuper H, et al. Mapping the global distribution of trachoma. Bull World Health Organ. 2005;83:913-919.

2.  World Health Organization. Report of the 2nd global scientific meeting on trachoma. Geneva, Switzerland: WHO; 2003:WHO/PBD/GET 03.1.

3.  West SK, Munoz B, Mkocha H, et al. Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol. 2001;8:137-144.

4.  Bowman RJ, Jatta B, Cham B, et al. Natural history of trachomatous scarring in the Gambia: results of a 12-year longitudinal follow-up. Ophthalmology. 2001;108:2219-2224.

5.  Schemann JF, Sacko D, Malvy D, et al. Risk factors for trachoma in Mali. Int J Epidemiol. 2002;31:194-201.

6.  Taylor HR, West SK, Mmbaga BB, et al. Hygiene factors and increased risk of trachoma in central Tanzania. Arch Ophthalmol. 1989;107:1821-1825.

7.  West SK, Congdon N, Katala S, et al. Facial cleanliness and risk of trachoma in families. Arch Ophthalmol. 1991;109:855-857.

8.  West SK, Munoz B, Lynch M, et al. Risk factors for constant, severe trachoma among preschool children in Kongwa, Tanzania. Am J Epidemiol.1996;143:73-78.

9.  Wright HR, Turner A, Taylor HR. Trachoma and poverty: unnecessary blindness further disadvantages the poorest people in the poorest countries. Clin Exp Optom. 2007;90:422-428.

10.  Miller K, Pakpour N, Yi E, et al. Pesky trachoma suspect finally caught. Br J Ophthalmol. 2004;88:750-751.

11.  West S, Lynch M, Turner V, et al. Water availability and trachoma. Bull World Health Organ. 1989;67:71-75.

12.  Emerson PM, Lindsay SW, Alexander N, et al. Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial. Lancet. 2004;363:1093-1098.

13.  World Health Organization. Primary health care level management of trachoma. http://www.who.int (last accessed 30 March 2016).

14.  Wright HR, Taylor HR. Clinical examination and laboratory tests for the estimation of trachoma prevalence in a remote setting: what are they really telling us? Lancet Infect Dis. 2005;5:313-320.

15.  Solomon AW, Foster A, Mabey DC. Clinical examination versus Chlamydia trachomatis assays to guide antibiotic use in trachoma control programmes. Lancet Infect Dis. 2006;6:5-6.

16.  Michel CE, Solomon AW, Magbanua JP, et al. Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study. Lancet. 2006;367:1585-1590.

17.  World Health Organization. Trachoma control: a guide for programme managers. 2006. http://www.who.int (last accessed 30 March 2016).

18.  Negrel AD, Taylor HR, West S. Guidelines for rapid assessment for blinding trachoma. Geneva, Switzerland: World Health Organization and International Trachoma Initiative; 2001.

19.  West SK, Bailey R, Munoz B, et al. A randomized trial of two coverage targets for mass treatment with azithromycin for trachoma. PLoS Negl Trop Dis. 2013;7:e2415.

20.  Yohannan J, Munoz B, Mkocha H, et al. Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results. JAMA Ophthalmol. 2013;131:431-436.

21.  House JI, Ayele B, Porco TC, et al. Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial. Lancet. 2009;373:1111-1118.

22.  Evans JR, Solomon AW. Antibiotics for trachoma. Cochrane Database Syst Rev. 2011;(3):CD001860.

23.  Bailey RL, Arullendran P, Whittle HC, et al. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet. 1993;342:453-456.

24.  Tabbara KF, Abu el-Asrar AM, Al-Omar O, et al. Single-dose azithromycin in the treatment of trachoma. Ophthalmology 1996;103:842-846.

25.  Dawson CR, Schachter J, Sallam S, et al. A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. Clin Infect Dis. 1997;24:363-368.

26.  Bowman RJ, Sillah A, Van Dehn C, et al. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Invest Ophthalmol Vis Sci. 2000;41:4074-4079.

27.  Porco TC, Gebre T, Ayele B, et al. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA. 2009;302:962-968.

28.  Fry AM, Jha HC, Lietman TM, et al. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis. 2002;35:395-402.

29.  Harding-Esch EM, Sillah A, Edwards T, et al; Partnership for Rapid Elimination of Trachoma (PRET) study group. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia. PLoS Negl Trop Dis. 2013;7:e2115.

30.  Lietman T, Porco T, Dawson C, et al. Global elimination of trachoma: how frequently should we administer mass chemotherapy. Nature Med. 1999;5:572-576.

31.  Melese M, Alemayehu W, Lakew T, et al. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma. JAMA. 2008;299:778-784.

32.  Gebre T, Ayele B, Zerihun M, et al. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial. Lancet. 2012;379:143-151.

33.  Hsieh YH, Bobo LD, Quinn TC, et al. Risk factors for trachoma: 6-year follow-up of children aged 1 and 2 years. Am J Epidemiol. 2000;152:204-211.

34.  Ejere HO, Alhassan MB, Rabiu M. Face washing promotion for preventing active trachoma. Cochrane Database Syst Rev. 2015;(2):CD003659.

35.  Ngondi J, Onsarigo A, Matthews F, et al. Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: a cross-sectional study. Lancet. 2006;368:589-595.

36.  Khandekar R, Ton TK, Do Thi P. Impact of face washing and environmental improvements on reduction of active trachoma in Vietnam - a public health intervention study. Ophthalmic Epidemiol. 2006;13:43-52.

37.  Haile M, Tadesse Z, Gebreselassie S, et al. The association between latrine use and trachoma: a secondary cohort analysis from a randomized clinical trial. Am J Trop Med Hyg. 2013;89:717-720.

38.  Abdou A, Munoz BE, Nassirou B, et al. How much is not enough? A community randomized trial of a Water and Health Education programme for trachoma and ocular C. trachomatis infection in Niger. Trop Med Int Health. 2010;15:98-104.

39.  Emerson PM, Lindsay SW, Walraven GE, et al. Effect of fly control on trachoma and diarrhoea. Lancet. 1999;353:1401-1403.

40.  West SK, Emerson PM, Mkocha H, et al. Intensive insecticide spraying for fly control after mass antibiotic treatment for trachoma in a hyperendemic setting: a randomised trial. Lancet. 2006;368:596-600.

41.  Frick KD, Melia BM, Buhrmann RR, et al. Trichiasis and disability in a trachoma-endemic area of Tanzania. Arch Ophthalmol. 2001;119:1839-1844.

42.  Dhaliwal P, Nagpal G, Bhatia MS. Health-related quality of life in patients with trachomatous trichiasis or entropion. Ophthalmic Epidemiol. 2006;13:59-66.

43.  Bowman RJ, Faal H, Myatt M, et al. Longitudinal study of trachomatous trichiasis in the Gambia. Br J Ophthalmol. 2002;86:339-343.

44.  Reacher M, Foster A, Huber J. Trichiasis surgery for trachoma: the bilamellar tarsal rotation procedure. Geneva, Switzerland: WHO; 1998;WHO/PBL/93.29.

45.  Reacher M, Munoz B, Alghassany A, et al. A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol. 1992;110:667-674.

46.  Zhang H, Kandel RP, Atakari HK, et al. Impact of oral azithromycin on recurrence of trachomatous trichiasis in Nepal over 1 year. Br J Ophthalmol. 2006;90:943-948.

47.  West S, Lynch M, Munoz B, et al. Predicting surgical compliance in a cohort of women with trichiasis. Int Ophthalmol. 1994;18:105-109.

48.  Oliva MS, Munoz B, Lynch M, et al. Evaluation of barriers to surgical compliance in the treatment of trichiasis. Int Ophthalmol. 1997-1998;21:235-241.

49.  Courtright P. Acceptance of surgery for trichiasis among rural Malawian women. East Afr Med J. 1994;71:803-804.

50.  Rabiu MA, Abiose A. Magnitude of trachoma and barriers to uptake of lid surgery in a rural community of northern Nigeria. Ophthalmic Epidemiol. 2001;8:181-190.

51.  Bowman RJ, Faal H, Jatta B, et al. Longitudinal study of trachomatous trichiasis in The Gambia: barriers to acceptance of surgery. Invest Ophthalmol Vis Sci. 2002;43:936-940.

52.  West SK, West ES, Alemayehu W, et al. Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia. Arch Ophthalmol 2006;124:309-314.

53.  Nagpal G, Dhaliwal U, Bhatia MS. Barriers to acceptance of intervention among patients with trachomatous trichiasis or entropion presenting to a teaching hospital. Ophthalmic Epidemiol. 2006;13:53-58.

54.  West ES, Munoz B, Imeru A, et al. The association between epilation and corneal opacity in eye with trachomatous trichiasis. Br J Ophthalmol. 2006;90:171-174.

55.  Rajak SN, Habtamu E, Weiss HA, et al. Surgery versus epilation for the treatment of minor trichiasis in Ethiopia: a randomised controlled noninferiority trial. PLoS Med. 2011;8:e1001136.

56.  Rajak SN, Habtamu E, Weiss HA, et al. Absorbable versus silk sutures for surgical treatment of trachomatous trichiasis in Ethiopia: a randomised controlled trial. PLoS Med. 2011;8:e1001137

57.  Cochereau I, Goldschmidt P, Goepogui A, et al. Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial. Br J Ophthalmol. 2007;91:667.

使用此内容应接受我们的免责声明